Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,970 | 20,375 | 29,876 | 11,737 | 9,081 |
| Marketable Securities | 40,704 | 62,460 | N/A | 113,877 | 133,596 |
| TOTAL | $77,990 | $83,927 | $33,766 | $128,772 | $146,320 |
| Non-Current Assets | |||||
| PPE Net | 81 | 102 | 1,432 | 529 | 554 |
| Other Non-Current Assets | 646 | 610 | 536 | 1,087 | 1,165 |
| TOTAL | $727 | $712 | $1,968 | $1,616 | $1,719 |
| Total Assets | $78,717 | $84,639 | $35,734 | $130,388 | $148,039 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 64 | 676 | 3,417 | 2,473 | 1,828 |
| Accrued Expenses | 953 | 1,807 | 3,660 | 10,765 | 11,592 |
| TOTAL | $1,348 | $2,814 | $7,285 | $13,563 | $13,738 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 500 | 583 | 466 | 1,881 | 1,773 |
| TOTAL | $500 | $583 | $466 | $1,881 | $1,773 |
| Total Liabilities | $1,848 | $3,397 | $7,751 | $15,444 | $15,511 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,343 | 3,342 | 3,342 | 3,331 | 3,380 |
| Common Shares | 3 | 3 | N/A | 3 | 3 |
| Retained earnings | -232,261 | -226,900 | -102,051 | -190,517 | -171,321 |
| Other shareholders' equity | -13 | -12 | 129,825 | -21 | -31 |
| TOTAL | $76,869 | $81,242 | $27,983 | $114,944 | $132,528 |
| Total Liabilities And Equity | $78,717 | $84,639 | $35,734 | $130,388 | $148,039 |